SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-016405
Filing Date
2022-06-10
Accepted
2022-06-10 11:35:37
Documents
1
Period of Report
2022-06-08

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3743
  Complete submission text file 0001493152-22-016405.txt   5178
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Issuer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LIPOCINE, INC. 675 ARAPEEN DRIVE, STE. 202 SALT LAKE CITY UT 84108
Business Address
Higuchi John W. (Reporting) CIK: 0001579891 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36357 | Film No.: 221008072